Pai Ramdas G, Varadarajan Padmini
Department of Medicine, University of California Riverside School of Medicine, Riverside, CA 92521, USA.
Department of Medicine, California University of Science and Medicine, Colton, CA 92324, USA.
J Clin Med. 2024 May 22;13(11):3043. doi: 10.3390/jcm13113043.
The syndrome of heart failure (HF) with preserved ejection fraction (HFpEF) makes up about half of the HF population. The HF mechanisms in these patients are varied and not fully understood. In addition, the term "diastolic HF" was switched to HFpEF because of difficulties in measuring the left ventricular (LV) diastolic performance. In the late stages, HFpEF carries a prognosis that is as bad as or worse than that of HFrEF. Hence, it is important to recognize LV diastolic impairment at an earlier stage so that the causal mechanisms, if any, can be treated to retard its progression. Despite the availability of numerous disease-modifying agents for HFrEF, there are hardly any available treatments for HFpEF. With our aging population, there will be an epidemic of HFpEF and hence this entity needs attention and respect. In this paper, we review the fundamental mechanisms of HFpEF, the physiology of LV filling and how LV diastolic function can be comprehensively measured. We also speculate how this may help with the early recognition of diastolic HF and its treatment.
射血分数保留的心力衰竭(HFpEF)综合征约占心力衰竭患者群体的一半。这些患者的心力衰竭机制多种多样,尚未完全明确。此外,由于测量左心室(LV)舒张功能存在困难,“舒张性心力衰竭”这一术语已被改为HFpEF。在晚期,HFpEF的预后与射血分数降低的心力衰竭(HFrEF)一样差或更差。因此,尽早识别左心室舒张功能障碍很重要,这样如果存在任何因果机制,就可以进行治疗以延缓其进展。尽管有许多改善病情的药物可用于HFrEF,但几乎没有任何可用的治疗方法用于HFpEF。随着人口老龄化,HFpEF将会流行,因此这个实体需要得到关注和重视。在本文中,我们回顾了HFpEF的基本机制、左心室充盈的生理学以及如何全面测量左心室舒张功能。我们还推测这可能如何有助于舒张性心力衰竭的早期识别及其治疗。